Sponsored Videos

Give a quick overview of the oligonucleotide market, what is happening. Cover the typical challenges with oligonucleotide synthesis in the process development phase and solutions for those. Key considerations when scaling up oligonucleotide synthesis

Innovation has brought about a diversification of therapeutics molecules. In this discovery interview we will explore what mechanistic modelling is and how you can use it to develop these diverse therapeutics and what challenges this brings to the future of your process development.

G-CON is fulfilling the needs of reliable and fast deliverable capacities for the biopharmaceutical industry. Through a well-defined customer needs driven approach to design, production, installation and qualification, G-CON provides a fully functional cleanroom product portfolio enabling reliable biocapacity planning on-time and within-budget.

Discover how we make our best-in-class agarose chromatography resins using our patented manufacturing technology Jetting.